 |
 |
 |
|
|
| 05 | 05 | 06 Chlorogen receives international honor ST. LOUIS – Chlorogen, a client of the Nidus Center for Scientific Enterprise in St. Louis, today was named 2006 Outstanding Incubator Client in the technology category at the National Business Incubation Association's 20th International Conference on Business Incubation. | more | 01 | 19 | 06 Chlorogen secures additional $6 million in venture funding ST. LOUIS – Chlorogen, Inc., a venture-backed biopharmaceutical company focused on the development and manufacture of proteins for human therapy, has secured $6 million in additional venture funding. | more | 09 | 15 | 05 Dow AgroSciences, Chlorogen to co-develop
chloroplast transformation INDIANAPOLIS – Dow AgroSciences LLC has entered into two research agreements with Chlorogen, Inc. that could lead to commercial licenses to use chloroplast transformation technology in Dow AgroSciences’ animal health and agricultural biotechnology businesses. | more | 08 | 16 | 05 Chlorogen strengthens intellectual property
position ST. LOUIS – Chlorogen, Inc. has acquired an exclusive license to chloroplast transformation patents held by Rutgers, The State University of New Jersey. These patents, developed at the Waksman Institute, give the company broad freedom to operate in the field of chloroplast transformation technology (CTT)™. | more | 08 | 06 | 03 Chlorogen’s new method of altering
crop plants may cut drug costs, ST. LOUIS – Chlorogen, Inc., a St. Louis-based biotechnology company, has secured venture funding to develop its patented chloroplast technology to produce plant-made proteins. Chlorogen’s initial focus will be on developing pharmaceutical proteins in tobacco. | more |
|
||